Kanglong Chemical announced that Pharmaron Holdings Limited, the shareholder holding more than 5% of the company's shares and the actual controller, plans to transfer 18.373 million shares of the company's shares through an inquiry and transfer, accounting for 1.00% of the company's total share capital and 10.18% of its shares. The reason for the transfer is due to its own capital requirements. This inquiry and transfer was carried out by Huatai Joint Securities Organization. The lower price limit is not less than 70% of the average stock transaction price in the 20 trading days before the date the subscription invitation was sent. The transferee is an eligible institutional investor, and the transferred shares cannot be transferred within 6 months. This transfer will not result in a change in the company's control, and there is a risk of uncertainty about implementation.

Kanglong Chemical announced that Pharmaron Holdings Limited, the shareholder holding more than 5% of the company's shares and the actual controller, plans to transfer 18.373 million shares of the company's shares through an inquiry and transfer, accounting for 1.00% of the company's total share capital and 10.18% of its shares. The reason for the transfer is due to its own capital requirements. This inquiry and transfer was carried out by Huatai Joint Securities Organization. The lower price limit is not less than 70% of the average stock transaction price in the 20 trading days before the date the subscription invitation was sent. The transferee is an eligible institutional investor, and the transferred shares cannot be transferred within 6 months. This transfer will not result in a change in the company's control, and there is a risk of uncertainty about implementation.